TrialJournal of clinical immunology2012

Efficacy, safety and pharmacokinetics of a novel subcutaneous immunoglobulin, Evogam®, in primary immunodeficiency.

Marianne B Empson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.